Sreenivasaiah Menasinakai

Benzimidazoles: novel mycobacterial gyrase inhibitors from scaffold morphing.

V. Sambandamurthy, Sreevalli Sharma, J. Reddy, 2014, ACS medicinal chemistry letters.

Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate

D. Wirth, D. Fidock, Pavithra Viswanath, 2015, Nature Communications.

Genetic and chemical validation identifies Mycobacterium tuberculosis topoisomerase I as an attractive anti-tubercular target.

C. Eyermann, G. Balakrishnan, F. Reck, 2015, Tuberculosis.

Thiazolopyridone ureas as DNA gyrase B inhibitors: optimization of antitubercular activity and efficacy.

Vijay T. Ahuja, D. Ogg, P. Boriack-Sjodin, 2014, Bioorganic & medicinal chemistry letters.

N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compounds.

D. Fidock, F. Gamo, A. Srivastava, 2014, Journal of medicinal chemistry.

Assessment of Mycobacterium tuberculosis Pantothenate Kinase Vulnerability through Target Knockdown and Mechanistically Diverse Inhibitors

Anirban Ghosh, K. Mukherjee, V. Ramachandran, 2014, Antimicrobial Agents and Chemotherapy.

Whole cell screen based identification of spiropiperidines with potent antitubercular properties.

Vasanthi Ramachandran, Riccardo Manganelli, S. Cole, 2015, Bioorganic & medicinal chemistry letters.

Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis.

Anirban Ghosh, K. Mukherjee, S. Hoffner, 2014, Journal of medicinal chemistry.

Genetic and chemical validation identifies Mycobacterium tuberculosis topoisomerase I as an attractive anti-tubercular target.

C. Eyermann, G. Balakrishnan, F. Reck, 2015, Tuberculosis.